Instructions for Irunin (Itraconazole)
English product name
Irunin
Release form
caps. 100 mg: 5, 6, 7, 10, 12, 14, 15, 18, 20, 21, 28, 30, 42 or 45 pcs
Description
The capsules are №0 in size, yellow in colour, and the capsule contents are white or almost white spherical pellets.
1 cap.
Itraconazole 100 mg
ATC codes
J02AC02 Itraconazole
Clinical-pharmacological groups / Group affiliation
Antifungal preparation
Active substance
Itraconazole
Pharmacotherapy group
Antifungal agent
Testimony Irunin:
- Vulvovaginal candidiasis
- skin
- oral
- eye
- onichomycosis caused by dermatophytes and/or yeast
- systemic mycosis (including systemic aspergillosis,
- candidiasis,
- cryptococcosis,
- histoplasmosis,
- sporotrichosis,
- paracocydiasis,
- blastomycosis, and other rarely occurring systemic and tropical mycosis).
Method of use, course and dosage Itraconazole:
Inside 100 mg once/day or 200 mg 1-2 times/day, the duration of treatment depends on the etiology of the disease.
Pharmacological effect Irunin:
Antifungal agent derived from triazole. The mechanism of action is related to the ability to inhibit cytochrome P450-dependent enzymes of sensitive fungi, which leads to disruption of ergosterol synthesis of the cell wall of the fungus. It has a wider range of antifungal effects than ketoconazole.
